Astrana Health (NASDAQ:ASTH – Free Report) had its target price increased by Truist Financial from $50.00 to $59.00 in a research report sent to investors on Friday, Benzinga reports. They currently have a buy rating on the stock.
Several other equities analysts have also recently issued reports on the company. Stifel Nicolaus lifted their price target on Astrana Health from $48.00 to $60.00 and gave the company a buy rating in a research report on Thursday, August 1st. Baird R W upgraded Astrana Health to a strong-buy rating in a research report on Thursday, May 30th. Finally, Robert W. Baird started coverage on Astrana Health in a report on Thursday, May 30th. They issued an outperform rating and a $54.00 target price on the stock. Four analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of Buy and an average price target of $55.75.
Check Out Our Latest Stock Analysis on ASTH
Astrana Health Price Performance
Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.01. Astrana Health had a return on equity of 10.22% and a net margin of 4.29%. The company had revenue of $486.30 million for the quarter, compared to analysts’ expectations of $440.68 million. During the same period last year, the firm earned $0.28 EPS. The firm’s revenue for the quarter was up 39.7% on a year-over-year basis. On average, research analysts expect that Astrana Health will post 1.42 earnings per share for the current fiscal year.
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Further Reading
- Five stocks we like better than Astrana Health
- Are Penny Stocks a Good Fit for Your Portfolio?
- How to Invest in Silver: A Beginner’s Guide
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Monday.com’s Stock Results Will Brighten Any Investor’s Week
- Why is the Ex-Dividend Date Significant to Investors?
- 3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.